REVIEWER
Dustin D. French Northwestern, USA REVIEW RETURNED 05-Oct-2018 
GENERAL COMMENTS
While study on Aspirin is negative, this study is important because it builds the growing evidence of linking CRAO and Stroke. With that said there are 2 additional papers that should be cited in addition to the park et al. 
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1 Reviewer Name: Se Joon Woo Institution and Country: Seoul National University Bundang Hospital, South Korea Please state any competing interests or state 'None declared': None This is a well-written paper investigating the important question of CRAO. As authors indicated, the incidence of CRAO is extremely low, thus RCT is difficult to conduct to achieve the primary outcome. In that sense, this paper can provide guidelines to the ophthalmologists about the use of aspirin for patients of CRAO and it is worth publication. There are several comments as follows. 1. Page 9. Authors mentioned they excluded patients who had a history of CRAO before enrollment. I recommend authors include the lack of history of CRAO for a specific period of time such as 1 or 2 years to exclude prior CRAO.
Thank you so much for the comment. In this study, we enrolled first-ever CRAO event. In addition, we have set a period of one year as the observation time for excluding the history of another retinal vascular occlusion. We have made the description clearer and more modified the flow-chart of patient enrollment. Action: On page 9, we have changed the sentence to "We excluded patients with a history of stroke (ICD-9-CM codes: 430-437) and retinal vascular occlusion ) within one year before the index date." We have revised Figure 1 as the attachment.
2. Page 9. I would like to ask if authors could exclude the concurrent ischemic stroke when the patients admitted for CRAO. Ischemic stroke can be diagnosed during the workup of CRAO, and concurrent CRAO could not be affected by the intake of aspirin intake after the CRAO attack.
Thank you so much for the comment. In our study, we have excluded the patient with ischemic stroke on day-0 of CRAO event. In addition, we included the patient with CRAO as the principal diagnosis. Theoretically, the patients with co-occurrence of CRAO and ischemic stroke were not included since acute ischemic stroke is a severe disease with high medical cost. The principal diagnosis should be the acute ischemic stroke for reimbursement if the patient had CRAO and concurrent ischemic stroke. We have revised the manuscript and make the description clearer. Action: On page 9, we have changed the sentence to "We identified patients had first-ever CRAO as principal diagnosis using the International Classification of Diseases, Revision 9, Clinical Modification (ICD-9-CM) code 362.31, from January 1, 1998, to December 31, 2013" 3. Page 4. The p values for AF was 0.083, thus it is difficult to mention it is a risk factor of ischemic stroke. Although I personally agree that AF may a risk factor of stroke, the p value indicates that this study has a weak statistical power to prove the hypothesis.
Thank you so much for pointing it out. We totally agree with your opinion. We have revised our manuscript and added more description of the finding. Action: On page 4, we have deleted the sentence regarding atrial fibrillation. On page 15, we have changed the sentence to "AF might have a trend to be associated with a higher risk of ischemic stroke after CRAO (HR, 2.44; P = 0.083)." On page 19, we have changed the sentence to "Although AF did not reach statistical significance, a trend of increased risk of ischemic stroke was observed." 4. Discussion. In the retrospective hospital-based cohort study by Hong et al. showed the significant risk factor of vascular events was large artery atherosclerosis such as carotid artery stenosis (HR 3.94). (Hong JH, Sohn SI, Kwak J, Yoo J, Ahn SJ, Woo SJ, Jung C, Yum KS, Bae HJ, Chang JY et al: Retinal artery occlusion and associated recurrent vascular risk with underlying etiologies. PloS one 2017, 12(6):e0177663.) As the data in this study did not include the large artery atherosclerosis, the propensity score matching might have been incomplete with possibility of bias. I recommend the authors mention this limitation and cite the above reference.
Thank you so much for your suggestion. It's a limitation for obtaining results of ultrasonography by using NHIRD. We have added the limitation and cited the reference in our manuscript. Action: On page 20, we have changed the sentence to "Regarding CRAO, readers may want to understand the association between carotid artery stenosis or atherosclerosis and subsequent ischemic stroke, yet we were not able to analyze this issue." On page 20, we have changed the sentence to "…a carotid ultrasonography was suggested for patients with an incident CRAO and large artery atherosclerosis was found to be associated with retinal artery occlusion…" We have cited the reference in the manuscript.
Page 13. Regarding to -> regarding the
Thank you so much for pointing it out. We have revised the sentence. Action: On page 13, we have changed the sentence to "Regarding the history of medication use, 7.3% and 7.4% of patients in the aspirin group and the aspirin-naive group had used statin, while only 0.2% and 0.9% of patients in the aspirin group and the aspirin-naive group had used warfarin."
Reviewer: 2 Reviewer Name: Dustin D. French Institution and Country: Northwestern, USA Please state any competing interests or state 'None declared': None Please leave your comments for the authors below 1. While study on Aspirin is negative, this study is important because it builds the growing evidence of linking CRAO and Stroke. With that said there are 2 additional papers that should be cited in addition to the park et al. Thank you so much for the suggestion. We have added the references to our manuscript and revised the description. Action: On page 6, we have changed the sentence to "Park et al. and French et al. demonstrated a significantly increased incidence of ischemic stroke after CRAO in Korea and the USA, especially during the first and second week of the CRAO event." On page 6, we have changed the sentence to "CRAO was described as a risk factor for ischemic stroke, coronary artery disease, critical carotid disease, and peripheral arterial occlusive disease." On page 16, we have added a sentence "In the US, French et al. also reported that incidence of ischemic stroke peaked 2 weeks after CRAO." We have cited the 2 references in our manuscript. Thank you so much for the comment. In our study, we used isolated time points rather than cumulative time points to calculate the event. We have revised the manuscript to make it clearer. Action: On page 13, we have changed the sentence to "The number of post-CRAO ischemic stroke events was stratified by weekly and monthly periods in separated time points" Thank you so much for the comment. In our study, we have set a 3-month wash-out period to exclude the patient with possible stroke attack before the CRAO event. In addition, we included the patient with CRAO as principal diagnosis in our study. Theoretically, the patients with co-occurrence of CRAO and ischemic stroke were not included since acute ischemic stroke is a severe disease with high medical cost and should be claimed as a principal diagnosis for reimbursement. We have revised our manuscript and made the description clearer. We also cited the reference in our manuscript. Action: On page 9, we have changed the sentence to "We identified patients had first-ever CRAO as principal diagnosis using the International Classification of Diseases, Revision 9, Clinical Modification (ICD-9-CM) code 362.31, from January 1, 1998, to December 31, 2013" On page 19, we have cited the reference and changed the sentence to "These findings suggest that CRAO is an early warning sign of ischemic stroke for patients with risk factors, and efforts to prevent a subsequent stroke and cardiovascular events, including a thorough cardiovascular examination and an immediate referral, should be performed as soon as possible after a CRAO occurrence." 4. If other stroke treatments were given aside from warfarin please indicate and net out.
Thank you so much for the comment. In addition to warfarin, we also recorded prescription of all anticoagulants, which were approved by the Taiwan National Health Insurance Administration, including heparins, direct thrombin inhibitors, novel oral anticoagulants (NOAC), etc. However, there was no participant with non-warfarin anticoagulants identified after propensity score matching in our study. Thank you so much for your suggestion. We have cited the two references and added more description regarding the discussion of Park and French's studies. Action: On page 6, we have changed the sentence to "Park et al. and French et al. demonstrated a significantly increased incidence of ischemic stroke after CRAO in Korea and the USA, especially during the first and second week of the CRAO event." On page 16, we have added a sentence "In the US, French et al. also reported that incidence of ischemic stroke peaked 2 weeks after CRAO." On page 16, we have added sentences "From our study, the number of patients who experienced an ischemic stroke was elevated during the first 2 weeks, especially the first 7 days, and gradually decreased after the second week. This finding was compatible with Park and French's investigations." We also cited Park and French's investigations as references.
VERSION 2 -REVIEW REVIEWER
Se Joon Woo Seoul National University Bundang Hospital, South Korea REVIEW RETURNED 23-Nov-2018 
GENERAL COMMENTS
Authors corrected the manuscript well and its quality has improved. In the objective of the abstract, "efficiency" should be replaced with "efficacy". 
REVIEWER

GENERAL COMMENTS
Nicely done.
